PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) was the recipient of a large decrease in short interest during the month of September. As of September 30th, there was short interest totaling 15,775 shares, a decrease of 73.7% from the September 15th total of 59,901 shares. Based on an average trading volume of 91 shares, the short-interest ratio is presently 173.4 days.
PureTech Health Price Performance
PureTech Health stock opened at $1.51 on Monday. The stock has a 50 day moving average of $1.57 and a two-hundred day moving average of $1.64. PureTech Health has a twelve month low of $1.45 and a twelve month high of $1.92.
PureTech Health Company Profile
PureTech Health plc is a biopharmaceutical company that develops medicines for complex diseases, with a focus on therapeutic approaches designed to address significant unmet patient needs. The company combines its own research and development activities with a model of creating, financing and advancing subsidiary companies that pursue distinct therapeutic programs.
PureTech’s research platform includes orally administered medicines and other treatments intended to influence biological pathways that are difficult to target with conventional drug-delivery methods.
See Also
- Five stocks we like better than PureTech Health
- Applied Digital Plugs Into Hyperscaler Buyout Bids
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
